Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOncimmune Regulatory News (ONC)

Share Price Information for Oncimmune (ONC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 2.00 (9.091%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 23.00
ONC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

26 Nov 2021 16:36

RNS Number : 7832T
Oncimmune Holdings PLC
26 November 2021
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEBLBDBUXDDGBL

Date   Source Headline
27th Jan 20207:00 amRNSNotice of Capital Markets Update
23rd Jan 202012:30 pmRNSConsortium of Liver Cancer Industry Leaders
7th Jan 20207:00 amRNSNotice of Half Year Results
7th Jan 20207:00 amRNSChange of Registered Address
12th Dec 20192:07 pmRNSWinner of BioNewsRound Award
29th Nov 20199:58 amRNSResults of Annual General Meeting
4th Nov 20192:46 pmRNSNotice of AGM and Posting of Annual Report
4th Nov 20197:00 amRNSDraw down of second tranche of credit facility
1st Nov 20197:10 amRNSOncimmune and Biodesix seal deal
31st Oct 20197:00 amRNSFinal Results
25th Oct 20197:00 amRNSNotice of Full Year Results ended May 2019
16th Oct 20195:01 pmRNSOncimmune welcomes NHS review of cancer screenings
23rd Sep 20197:00 amRNSKey appointments to further strengthen management
20th Sep 20192:32 pmRNSAppointment of Joint Broker
20th Sep 20197:00 amRNSEUR8.5m Credit Facility Secured
18th Sep 20197:00 amRNSOncimmune to Present at 2019 CBIIC
9th Sep 20197:30 amRNSPositive Results for ECLS Trial Presentation
3rd Sep 201912:00 pmRNSECLS at 2019 World Conference for Lung Cancer
1st Aug 201912:00 pmRNSSolebury Trout European Biotech Investor Day
15th Jul 20197:00 amRNSFurther Expansion in Spain for EarlyCDT Lung
4th Jul 201910:38 amRNSCommercialisation Partnership in Russia
2nd Jul 20197:00 amRNSProactive Investors One2One Investor Forum
28th Jun 20197:00 amRNSCommercialisation Agreement in US with Biodesix
26th Jun 20197:00 amRNSBusiness Update
4th Jun 20197:00 amRNSPositive Results for Early Cancer Detection Test
15th May 20197:00 amRNSRegulatory Approval in Israel for EarlyCDT®-Lung
10th May 20197:00 amRNSInitiation of a Multi-Centre Trial in China
17th Apr 20197:00 amRNSHolding(s) in Company
5th Apr 20197:00 amRNSAgreement for Portugal and Spain
2nd Apr 20197:00 amRNSAppointment of Parag Mallick to Scientific Board
1st Apr 20195:19 pmRNSHolding(s) in Company
1st Apr 20197:00 amRNSEarlyCDT®-Lung Registered in Columbia
25th Mar 20197:00 amRNSSpanish Private Hospital to Sell EarlyCDT®-Lung
19th Mar 20197:00 amRNSOncimmune acquires Protagen Diagnostics AG
13th Feb 20197:00 amRNSHalf Year Results
31st Jan 20197:00 amRNSNotice of Half Year Results
24th Jan 20197:00 amRNSGrant of Options and PDMR notification
23rd Jan 20197:00 amRNSOncimmune to host Science Day in London today
14th Jan 20197:00 amRNSOncimmune Science Day
20th Dec 20182:13 pmRNSOncimmune signs US distribution agreement
13th Dec 20187:00 amRNSOncimmune appoints new Scientific Board
6th Dec 20184:34 pmRNSSenior Leadership Team Appointments & Board Change
30th Nov 201810:46 amRNSResult of AGM
28th Nov 20187:10 amRNSDistribution Agreements & Registration Outside EU
5th Nov 20187:00 amRNSAnnual Report and Accounts and AGM Notification
31st Oct 20187:00 amRNSResults for the year ended 31 May 2018
1st Oct 20187:00 amRNSBusiness Update
28th Sep 20187:00 amRNSAppointment of Non-Executive Director
25th Sep 20183:45 pmRNSIASLC World Conference on Lung Cancer Presentation
25th Sep 20187:00 amRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.